HKEX Stock Code: 01093English|繁體|简体

2024 1Q Results

  • Revenue RMB8,983M, +11.5%
  • Underlying profit attributable to shareholders RMB1,724M, +11.6%
  • Reported profit attributable to shareholders RMB1,613M, +12.9%
  • Basic earnings per share (reported) RMB13.61 cents, +13.5%
  • Basic earnings per share (underlying profit) RMB14.55 cents, +12.3%

Highlight - 2024 1Q

Revenue
RMB8,983M, +11.5%
Underlying profit attributable to shareholders
RMB1,724M, +11.6%
Reported profit attributable to shareholders
RMB1,613M, +12.9%
Basic earnings per share (reported)
RMB13.61 cents, +13.5%
Basic earnings per share (underlying profit)
RMB14.55 cents, +12.3%

Corporate Governance

Corporate Governance

Financial Calendar

May
28
May
27
May
27
Mar
20
Mar
20

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.